Work

FG-3019, a human monoclonal antibody to CTGF, with gemcitabine/erlotinib in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.4_suppl.213

Authors: Vincent J. Picozzi, J. Marc Pipas, Albert Koong, Amato Giaccia, Nathan Bahary, Smitha S. Krishnamurthi, Charles D. Lopez, Peter J. O'Dwyer, Katharina Modelska, Vanessa Poolman, James Chou, Ming Zhong, Seth Porter, Tom Neff, Frank Valone

Institutions: Virginia Mason Medical Center, Dartmouth–Hitchcock Medical Center, Dartmouth Cancer Center, Stanford Medicine, Stanford University, University of Pittsburgh Medical Center, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Case Western Reserve University, Oregon Health & Science University, Abramson Cancer Center, University of Pennsylvania, FibroGen (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2243204557

Cites:

Cited by: 6

Related to: 10